SCHEMBL9554114

SCHEMBL9554114

CC(C)CCc1c(Cl)n(C(=O)Cc2ccccc2)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 2/20 0.36
AGTR2 P50052 2/20 0.36
BRS3 P32247 1/20 0.35
PPARG P37231 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9554903 0.92 AGTR1 (0.36) AGTR1AGTR2PPARG
SCHEMBL9532776 0.92 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL9036281 0.91 AGTR1 (0.38) AGTR1AGTR2
SCHEMBL9531692 0.91 AGTR1 (0.35) AGTR1AGTR2PPARG
SCHEMBL9531227 0.91 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9534448 0.91 AGTR1 (0.35) AGTR1AGTR2PPARG
SCHEMBL9529536 0.90 AGTR1 (0.38) AGTR1AGTR2PPARG
SCHEMBL9553731 0.90 AGTR2 (0.36) AGTR1AGTR2PPARG
SCHEMBL9553697 0.90 AGTR1 (0.34) AGTR1AGTR2PPARG
SCHEMBL9706155 0.89 AGTR1 (0.38) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed